Phase 1 clinical trial for Merah Putih vaccine huge leap: BRIN
The first phase clinical trial of the domestically-produced Merah Putih vaccine is a huge leap for independent vaccine development in Indonesia, the National Research and Innovation Agency (BRIN) head Laksana Tri Handoko has said. “This is a huge leap, not just for the Unair (Airlangga University) team, but also for